Page last updated: 2024-12-05

titanium isopropoxide

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth

Description

titanium(IV) isopropoxide : A titanium coordination entity consisting of a titanium(IV) cation with four propan-2-olate anions as counterions. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Cross-References

ID SourceID
PubMed CID110612
SCHEMBL ID15774
MeSH IDM0269015

Synonyms (47)

Synonym
tetraisopropyl orthotitanate
titanium, tetrakis(1-methylethoxy)-
titanic acid isopropyl ester
tyzor tpt
titanium isopropoxide (ti(oc3h7)4)
tetraisopropoxytitanium
ti isopropylate
tetrakis(isopropoxy)titanium
titanium(4+) isopropoxide
titanium tetraisopropoxide
2-propanol, titanium(4+) salt
546-68-9
tetraisopropyl titanate
isopropyl alcohol titanium(4+) salt
isopropyl titanate(iv) ((c3h7o)4ti)
titanium(4+) tetrapropan-2-olate
orgatix ta 10
titanium tetrakis(isopropoxide)
titanium tetra-n-propoxide
a 1 (titanate)
titanium isopropoxide
tetraisopropoxide titanium
titanium(iv) isopropoxide
titanium(iv) isopropoxide, 97%
titanium(iv) isopropoxide, 99.999% trace metals basis
NCGC00164085-01
titanium(iv) isopropoxide, >=97.0%
53339-36-9
AKOS005721081
BBL011490
STL146602
68585-67-1
tetraisopropyl titanate di(dioctylphosphite)
einecs 271-575-5
titanium(iv) i-propoxide
BP-21066
SCHEMBL15774
titanium tetra(isopropoxide)
tetrakis(propan-2-yloxy)titanium
tetra-iso-propyl orthotitanate
titanium, tetrakis(isopropoxy)-
tetra-iso-propyl titanate
isopropyl titanate (iv)
DTXSID5027196
mfcd00008871
titanium(iv) isopropoxide, packaged for use in deposition systems
BCP23448
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Protein Targets (1)

Potency Measurements

ProteinTaxonomyMeasurementAverage (µ)Min (ref.)Avg (ref.)Max (ref.)Bioassay(s)
AR proteinHomo sapiens (human)Potency0.00110.000221.22318,912.5098AID588515
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (45)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's4 (8.89)18.2507
2000's20 (44.44)29.6817
2010's21 (46.67)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other46 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]